Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CORT-X: CORT108297 for Acute Stress in Allocortex
NCT04601038Phase 2Recruiting
- Sponsor
- Johns Hopkins University
- Start
- Jun 2021
- Primary completion
- Nov 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of cort108297 in Alzheimer's disease (AD), Mild Cognitive Impairment (MCI), sponsored by Johns Hopkins University. Started Jun 2021; status: recruiting.
02
Drugs
cort108297
03
Conditions
Alzheimer's disease (AD)Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on NCT04601038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04601038.